[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Ethics::
peer-review::
Indexing::
Article types::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Journal DOI

AWT IMAGE

..
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 
This Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0
..
:: Volume 27 - ::
J Babol Univ Med Sci. 2025; Volume 27 Back to browse issues page
Comparison of the Antioxidant and Anti-Inflammatory Effects of Silymarin and Nano-Silymarin in Hyperlipidemic Rats
R Mohebbati , MA Momeni-Moghaddam , S Mehrabi , A Abbasnezhad * , M Shokrgozar , M Alishahi , D Salarbashi , SH Abtahi , Z Heydarnia
1.Nursing Research Center, Gonabad University of Medical Sciences, Gonabad, I.R.Iran. , abbasnezhad.abbasali@gmail.com
Abstract:   (383 Views)
Background and Objective: For centuries, medicinal plants have been used in the treatment of many diseases and hyperlipidemia. The present study was conducted to compare the antioxidant and anti-inflammatory effects of silymarin and nano-silymarin in hyperlipidemic rats receiving a high-fat diet (HFD).
Methods: In this experimental study, 35 male rats were divided into 5 groups of 7, including control, negative control (HFD), HFD and atorvastatin (20 mg/kg) (positive control), HFD and silymarin (100 mg/kg), and HFD and nano-silymarin (100 mg/kg). Receiving a high-fat diet for 12 weeks induced oxidative stress. Drugs were administered through gavage feeding for 12 weeks. Finally, blood samples were taken to measure lipid profile, tumor necrosis factor alpha (TNF-α), interleukin 17, malondialdehyde (MDA), and superoxide dismutase (SOD).
Findings: Nano-silymarin was able to significantly reduce triglyceride levels by 2.93 units compared to the negative control (p<0.001), but the reduction of cholesterol and LDL-C by nano-silymarin was not significant. TNF-α in the negative control group was significantly higher by 31 units compared to the control (p=0.006). TNF-α and interleukin 17 levels were not significantly reduced in the groups receiving atorvastatin, silymarin and nano-silymarin compared to the negative control group. MDA levels in the negative control group increased by 0.8 units compared to the control group (p=0.001), but in the silymarin, nano-silymarin and atorvastatin groups, they showed a significant decrease by 0.8, 1 and 0.9 units compared to the negative control group, respectively (p<0.001).
Conclusion: According to the results of this study, the use of nano-silymarin compared to silymarin in rats receiving a high-fat diet led to a relative reduction in lipid profiles, but there was no difference in terms of antioxidant and anti-inflammatory properties.
Keywords: Silymarin, Nanoparticles, Oxidative Stress, Inflammation, Hyperlipidemia.
Full-Text [PDF 390 kb]   (33 Downloads)    
Type of Study: Experimental | Subject: Physiology
Received: 2024/08/18 | Accepted: 2024/10/12 | Published: 2025/11/17
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohebbati R, Momeni-Moghaddam M, Mehrabi S, Abbasnezhad A, Shokrgozar M, Alishahi M, et al . Comparison of the Antioxidant and Anti-Inflammatory Effects of Silymarin and Nano-Silymarin in Hyperlipidemic Rats. J Babol Univ Med Sci 2025; 27
URL: http://jbums.org/article-1-12203-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 27 - Back to browse issues page
مجله علمی دانشگاه علوم پزشکی بابل Journal of Babol University of Medical Sciences

The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.05 seconds with 43 queries by YEKTAWEB 4722